中国药物滥用防治杂志
中國藥物濫用防治雜誌
중국약물람용방치잡지
ZHONGGUO YAOWU LANYONG FANGZHI ZAZHI
2014年
5期
259-261,266
,共4页
白凤凤%李涛%刘娟%孙伟%高营
白鳳鳳%李濤%劉娟%孫偉%高營
백봉봉%리도%류연%손위%고영
度洛西汀%酒依赖%抑郁
度洛西汀%酒依賴%抑鬱
도락서정%주의뢰%억욱
duloxetine%alcohol Abuse%depression
目的:探讨度洛西汀在慢性酒依赖伴抑郁患者中的临床疗效及安全性。方法:将符合条件的66例慢性酒依赖伴抑郁患者随机分成两组,分别给予度洛西汀联合常规戒酒治疗(研究组)和常规戒酒治疗(对照组),进行8周的系统治疗,使用HAMD(汉密尔顿抑郁量表),HAMA(汉密尔顿焦虑量表),CGI(临床疗效总体评估量表),饮酒渴求度评估其疗效;以 TESS (副反应量表)和有关的实验室检查评定药物副反应。结果:治疗以后,研究组与对照组相比较,研究组第1、2、4、8周 HAMD-17、HAMA 、CGI 评分明显下降(P <0.05或 P <0.01);与对照组相比,研究组第1、2、4、8周的饮酒渴求度明显降低(P <0.05或 P <0.01)。结论:度洛西汀治疗酒依赖伴抑郁安全有效,并能明显降低酒依赖患者的心理渴求。
目的:探討度洛西汀在慢性酒依賴伴抑鬱患者中的臨床療效及安全性。方法:將符閤條件的66例慢性酒依賴伴抑鬱患者隨機分成兩組,分彆給予度洛西汀聯閤常規戒酒治療(研究組)和常規戒酒治療(對照組),進行8週的繫統治療,使用HAMD(漢密爾頓抑鬱量錶),HAMA(漢密爾頓焦慮量錶),CGI(臨床療效總體評估量錶),飲酒渴求度評估其療效;以 TESS (副反應量錶)和有關的實驗室檢查評定藥物副反應。結果:治療以後,研究組與對照組相比較,研究組第1、2、4、8週 HAMD-17、HAMA 、CGI 評分明顯下降(P <0.05或 P <0.01);與對照組相比,研究組第1、2、4、8週的飲酒渴求度明顯降低(P <0.05或 P <0.01)。結論:度洛西汀治療酒依賴伴抑鬱安全有效,併能明顯降低酒依賴患者的心理渴求。
목적:탐토도락서정재만성주의뢰반억욱환자중적림상료효급안전성。방법:장부합조건적66례만성주의뢰반억욱환자수궤분성량조,분별급여도락서정연합상규계주치료(연구조)화상규계주치료(대조조),진행8주적계통치료,사용HAMD(한밀이돈억욱량표),HAMA(한밀이돈초필량표),CGI(림상료효총체평고량표),음주갈구도평고기료효;이 TESS (부반응량표)화유관적실험실검사평정약물부반응。결과:치료이후,연구조여대조조상비교,연구조제1、2、4、8주 HAMD-17、HAMA 、CGI 평분명현하강(P <0.05혹 P <0.01);여대조조상비,연구조제1、2、4、8주적음주갈구도명현강저(P <0.05혹 P <0.01)。결론:도락서정치료주의뢰반억욱안전유효,병능명현강저주의뢰환자적심리갈구。
Objective:To explore the efficacy and safety of Duloxetine in treating alcohol abuse patients with depression. Methods:66 alcohol abuse patients with depression were randomly divided into Duloxetine group(n = 33)and Controll group(n = 33). Duloxe-tine group was treated by Duloxetine combined with regular treatment of alcohol abuse. Controll group was treated by regular treatment of alcohol abuse only. They were treated for 8 weeks. The efficacy and safety were evaluated at the baseline and at the end of week 1, 2,4,8 respectively. Results:At the end of the study,The Duloxetine group was significantly improved. The scales of HAMD/ HAMA decreased significantly at the end of week 1,2,4,8 in Duloxetine group(P <0. 05). The Duloxetine group was significantly lowered down the patients alcohol craving. Conclusion:Duloxetine is a safe and effective drug in the treatment of alcohol abuse patients with depression.